Suzhou, China

Xiaohong She

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Inventor Xiaohong She: Pioneering Cancer Treatment Innovations**

Introduction

Xiaohong She is an accomplished inventor based in Suzhou, China, known for her significant contributions to the field of cancer treatment. With a total of two patents, her work centers around enhancing T-cell function to improve immune responses against tumors and other related disorders.

Latest Patents

Her latest inventions include groundbreaking patents:

1. **Method for treating cancer using anti-CD137 antibody** - This patent details antibodies that bind to human CD137 or antigen-binding fragments, alongside nucleic acids encoding the same. It also describes therapeutic compositions to enhance T-cell function for the treatment of T-cell dysfunctional disorders and cancer.

2. **Anti-CD137 molecules and use thereof** - Similar to her first patent, this invention focuses on the application of antibodies binding to human CD137 or antigen-binding fragments, specifically aimed at bolstering T-cell responses to combat tumor immunity and cancer effectively.

Career Highlights

Xiaohong She is currently employed at Adagene Inc., where she applies her innovative expertise in the development of advanced therapeutics. Her dedication to cancer research highlights her passion for creating impactful medical solutions that contribute to the well-being of patients.

Collaborations

Throughout her career, Xiaohong has collaborated with esteemed colleagues, including Peter Peizhi Luo and Fangyong Du. These collaborations have played a pivotal role in advancing their shared vision of combating cancer through innovative antibody treatments.

Conclusion

Xiaohong She stands out as a formidable force in the medical innovation landscape. Her patents not only exemplify her commitment to cancer research but also represent significant advancements in enhancing immune responses. As the field of biotechnology continues to evolve, her work with Adagene Inc. promises to lead to groundbreaking therapies that could reshape cancer treatment strategies for future generations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…